Living donor liver transplantation for small infants aged less than 6 months: The experience of a single institute
Autor: | Cheng-Yen Chen, Niang Cheng Lin, Chinsu Liu, Hsin Lin Tsai, Jei Wen Chang, Yu Sheng Lee, Che Chuan Loong, Cheng Yuan Hsia, Yi-Ting Yeh, Pei Chen Tsao |
---|---|
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
medicine.medical_treatment Taiwan Liver transplantation Gastroenterology Biliary Atresia Biliary atresia Protein C deficiency Internal medicine Alagille syndrome Living Donors medicine Neonatal hemochromatosis Humans Retrospective Studies Hemophagocytic lymphohistiocytosis business.industry Graft Survival Infant Newborn Infant General Medicine medicine.disease Liver Transplantation Treatment Outcome Pediatrics Perinatology and Child Health Surgery Autoimmune hemolytic anemia Hemophagocytosis business |
Zdroj: | Journal of Pediatric Surgery. 56:1157-1161 |
ISSN: | 0022-3468 |
DOI: | 10.1016/j.jpedsurg.2021.03.022 |
Popis: | Liver transplantation (LT) for small infants6 months old is rare but becoming common as perioperative care improves. In Taiwan, living donor LT (LDLT) has expanded indications but is rarely performed for this age group because of unfavorable outcomes in the literature. We evaluated LDLT outcomes of patients6 months old.We identified infants6 months old undergoing LDLT between 2004 and 2019 at our hospital. Variables related to recipients, donors, surgeries, and outcomes were analyzed.Nine patients were identified. Indications for LT were biliary atresia (n = 2), Alagille syndrome (n = 1), protein C deficiency (n = 1), and acute liver failure (n = 5), including two patients with neonatal hemochromatosis, one with herpes simplex hepatitis, one with giant cell hepatitis with autoimmune hemolytic anemia, and one with hemophagocytic lymphohistiocytosis. Median age and weight at LT were 129 days and 4.8 kg, respectively. Graft types included left lateral segment (LLS, n = 4), hyper-reduced LLS (n = 4), and monosegment (n = 1). The median graft-to-recipient weight ratio was 4%. The median follow-up period was 14 months (range, 8 days to 127 months) with two mortalities, and two patients were totally weaned off immunosuppressants. Adjuvant therapies were required for patients with giant cell hepatitis and hemophagocytosis. Preoperative reconstructive imaging for estimating graft thickness facilitated surgical planning.Although LDLT is difficult to perform for small infants, outcomes are favorable and mainly dependent on underlying causes in addition to technical innovations. |
Databáze: | OpenAIRE |
Externí odkaz: |